Literature DB >> 17275456

Prevalence and risk factors for erectile dysfunction in the US.

Elizabeth Selvin1, Arthur L Burnett, Elizabeth A Platz.   

Abstract

PURPOSE: To assess the prevalence of erectile dysfunction and to quantify associations between putative risk factors and erectile dysfunction in the US adult male population.
METHODS: Cross-sectional analysis of data from 2126 adult male participants in the 2001-2002 National Health and Nutrition Examination Survey (NHANES). Erectile dysfunction assessed by a single question during a self-paced, computer-assisted self-interview. These data are nationally representative of the noninstitutionalized adult male population in the US.
RESULTS: The overall prevalence of erectile dysfunction in men aged >/=20 years was 18.4% (95% confidence interval [CI], 16.2-20.7), suggesting that erectile dysfunction affects 18 million men (95% CI, 16-20) in the US. The prevalence of erectile dysfunction was highly positively related to age but was also particularly high among men with one or more cardiovascular risk factors, men with hypertension, and men with a history of cardiovascular disease, even after age adjustment. Among men with diabetes, the crude prevalence of erectile dysfunction was 51.3% (95% CI, 41.9-60.7). In multivariable analyses, erectile dysfunction was significantly and independently associated with diabetes, lower attained education, and lack of physical activity.
CONCLUSIONS: The high prevalence of erectile dysfunction among men with diabetes and hypertension suggests that screening for erectile dysfunction in these patients may be warranted. Physical activity and other measures for the prevention of cardiovascular disease and diabetes may prevent decrease in erectile function.

Entities:  

Mesh:

Year:  2007        PMID: 17275456     DOI: 10.1016/j.amjmed.2006.06.010

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  159 in total

1.  Erectile dysfunction in opioid users: lack of association with serum testosterone.

Authors:  Patricia A Cioe; Peter D Friedmann; Michael D Stein
Journal:  J Addict Dis       Date:  2010-10

Review 2.  Should patients with erectile dysfunction be evaluated for cardiovascular disease?

Authors:  Kenneth A Ewane; Hao-Cheng Lin; Run Wang
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

3.  Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.

Authors:  Alexander W Pastuszak; Daniel A Hyman; Naveen Yadav; Guilherme Godoy; Larry I Lipshultz; Andre B Araujo; Mohit Khera
Journal:  J Sex Med       Date:  2015-03-02       Impact factor: 3.802

4.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

5.  Association between chronic obstructive pulmonary disease and risk of erectile dysfunction: a systematic review and meta-analysis.

Authors:  Lianmin Luo; Shankun Zhao; Jiamin Wang; Yangzhou Liu; Zhiguo Zhu; Qian Xiang; ZhiGang Zhao
Journal:  Int J Impot Res       Date:  2019-07-01       Impact factor: 2.896

6.  Early-stage Type 2 Diabetes Mellitus Impairs Erectile Function and Neurite Outgrowth From the Major Pelvic Ganglion and Downregulates the Gene Expression of Neurotrophic Factors.

Authors:  Hotaka Matsui; Biljana Musicki; Nikolai A Sopko; Xiaopu Liu; Paula J Hurley; Arthur L Burnett; Trinity J Bivalacqua; Johanna L Hannan
Journal:  Urology       Date:  2016-09-14       Impact factor: 2.649

7.  A study of sexuality and health among older adults in the United States.

Authors:  Stacy Tessler Lindau; L Philip Schumm; Edward O Laumann; Wendy Levinson; Colm A O'Muircheartaigh; Linda J Waite
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

8.  Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With Placebo.

Authors:  John P Mulhall; Martin Carlsson; Vera Stecher; Li-Jung Tseng
Journal:  J Sex Med       Date:  2018-05-09       Impact factor: 3.802

Review 9.  Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.

Authors:  Sharon A Huang; Janette D Lie
Journal:  P T       Date:  2013-07

10.  Considerations for national public health leadership in advancing sexual health.

Authors:  Megan B Ivankovich; Kevin A Fenton; John M Douglas
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.